Dr. Alexander “Zan” Fleming is Founder and Executive Chairman of Kinexum, a company of professionals from across the world with diverse expertise in developing drugs, biotech products, medical devices, and digital health technologies. He is also President and Co-Founder of Kitalys Institute. Dr. Fleming received his MD and internal medicine training from Emory, fellowship training in endocrinology at Vanderbilt and metabolism at National Institutes of Health, where he was a senior fellow.
Dr. Fleming coined the term, Metabesity, which refers to the constellation of cancer, heart and neurologic diseases, diabetes and the aging process itself, all which share common metabolic root causes and potential preventive therapies. He organized the first Congress on Metabesity in London in October 2017, followed by the second conference in Washington, DC in October 2019. The third and fourth conferences were held virtually with over 80 speakers and 900 registrants in October 2020 and 2021. In 2020, Dr. Fleming founded the not-for-profit Kitalys Institute as a means of producing Metabesity conferences and advancing all measures that can improve health and healthspan.